Although aneuploidy in cancer genomes strongly correlates with mutations in TP53 [74], Zeng and colleagues reported that cyclin E-induced RS drives p53-dependent whole-genome duplication, an important driver of aneuploidy [75]. This evidence concerns the gene TP53 and cancer.